Edition:
India

People: Brainsway Ltd (BWAY.OQ)

BWAY.OQ on NASDAQ Stock Exchange Global Market

9.00USD
11 Nov 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$9.00
Open
$9.21
Day's High
$9.21
Day's Low
$9.00
Volume
1,324
Avg. Vol
3,247
52-wk High
$12.38
52-wk Low
$8.31

Zangen, Abraham 

Prof. Abraham Zangen, Ph.D. is Director of the Company. Professor Zangen is the Head of the Brain Stimulation and Behavior Lab and the Chair of the PsychoBiology Brain Program at Ben-Gurion University in Israel. His research is directed at identifying and understanding altered neuroplasticity in psychiatric disorders, primarily depression, addiction and ADHD, utilizing brain stimulation and imaging techniques to explore mechanisms and potential clinical applications. He co-developed, along with Dr. Yiftach Roth, the Deep TMS coil which serves as Brainsway's platform technology. Professor Zangen has published over 150 peer reviewed articles, reviews and book chapters. He has been awarded numerous prizes for his scientific achievements, including the Medical Futures Innovation Award in London, the Sieratzki Prize for Advances in Neuroscience and the Juludan Prize at the Technion. He has also received several distinguished research grants, including from the National Institutes of Health, H2020 and the Israel Science Foundation.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --